Stockreport

Rare manufacturing glitch raises concern over CAR-T therapies: study [Reuters]

bluebird bio, Inc.  (BLUE) 
Last bluebird bio, inc. earnings: 2/18 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: investor.bluebirdbio.com/investor-overview
PDF Rare manufacturing glitch raises concern over CAR-T therapies: study | Reuters 4 Min Read CHICAGO (Reuters) - A single leukemia cell inadvertently got mixed in with a ba [Read more]